Back to search

Netherlands· NL-6b082f05185c

Saflutan 15 microgram/ml oogdruppels, oplossing, verpakking voor eenmalig gebruik

A tafluprost product containing tafluprost, registered in Netherlands by BModesto B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC S01EE05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSaflutan 15 microgram/ml oogdruppels,…ATCS01EE05REGISTER NO.NL-6b082f05185cPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tafluprost is registered in 16 of 19 countries.

Countries holding a registration under ATC S01EE05 (tafluprost), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Tafluprost · ATC S01EE05

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TAFLUPROST
Manufacturer
BModesto B.V.
Country
Netherlands (NL)
ATC code
S01EE05
ATC class
Tafluprost
Defined daily dose
0.1 ml, AT
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    130801//103823

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tafluprost in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tafluprost products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Saflutan
  • Belgium · Saflutan
  • Bulgaria · Taflotan, Тафлотан
  • Cyprus · Saflutan, Taflotan
  • Czechia · Taflotan
  • Germany · Taflotan, Taflotan Sine
  • Denmark · Taflotan, Taflotan Sine
  • Estonia · Tafdera, Taflotan
  • Spain · Saflutan, Taflotan
  • Finland · Taflotan, Taflotan Sine
  • France · Saflutan, Tafluprost Rph Pharmaceuticals
  • United Kingdom (Northern Ireland) · Saflutan, Tafluprost Brown & Burk Uk
  • Greece · Saflutan, Taflotan
  • Croatia · Saflutan
  • Hungary · Taflotan
  • Ireland · Saflutan
  • Iceland · Taflotan, Taflotan Sine
  • Italy · Safluround, Saflutan
  • Lithuania · Taflotan
  • Luxembourg · Saflutan, Tafluprost Micro Labs
  • Latvia · Taflotan
  • Malta · Saflutan
  • Norway · Taflotan, Taflotan Sine
  • Poland · Taflotan, Taflotan Multi
  • Portugal · Saflutan, Taflotan
  • Romania · Saflutan
  • Sweden · Taflotan, Taflotan Sine
  • Slovenia · Saflutan
  • Slovakia · Taflotan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/58cd8bab-1526-41ab-90c6-39b5fdc1a644
GET /v1/drugs/58cd8bab-1526-41ab-90c6-39b5fdc1a644?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103823_smpc.pdf",
  "strength": null,
  "atc_label": "Tafluprost",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130801",
  "excipients": [
    "DINATRIUMEDETAAT 2-WATER",
    "GLYCEROL (E 422)",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "TAFLUPROST"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130801.pdf",
  "authorised_at": "2023/02/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130801//103823",
  "additional_monitoring": "N"
}

See everything about tafluprost.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.